Pumping to Up Maternal Milk Production for Preterms
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Nov 1, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Pumping to Up Maternal Milk Production for Preterms," is designed to explore how often mothers should pump breast milk to increase their supply, especially for babies born prematurely. The main question researchers want to answer is whether pumping every 2 hours leads to more breast milk than pumping every 3 hours. Mothers who participate will be divided into two groups: one group will pump every 2 hours, while the other will pump every 3 hours. They will keep track of how much milk they produce each day for the first 28 days of their baby's life.
To be eligible for this trial, mothers need to have babies who were born before 32 weeks of pregnancy, weigh under 1500 grams at birth, and have been legally consented for the study. However, infants who are severely ill, have terminal conditions, or have major health issues are not eligible to participate. If you decide to join this study, you will help researchers understand how pumping frequency affects milk supply, which could benefit many families in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inborn infants \<32 weeks gestation
- • Out-born infants transferred to our facility \<48hours of life
- • Infants \<1500 grams at birth
- • Infants whose parents/ guardians have provided legal consent for study participation
- Exclusion Criteria:
- • Infants with birthing persons' that are severe/critically ill
- • Birthing persons of infants \<18 years old
- • Infants with terminal illness or decision to withhold or limit support
- • infants with major congenital anomalies, chromosomal disorders, or congenital infections
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported